Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsGlenmarkpharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy HPCL, HCL Tech; Sell BHEL

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Bull's Eye: Buy DCB, Shree Renuka, Gitanjali Gems

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • SP Tulsian`s view on Strides Arcolab

      SP Tulsian, sptulsian.com shares his view on Strides Arcolab and he says that the deal is positive for the company.

    • Glenmark Pharma has target of Rs 310- 315: Sukhani

      Glenmark Pharma has target of Rs 310- 315, says Sudarshan Sukhani, s2analytics.com.

    • Glenmark Pharma may rally upto Rs 400, says PN Vijay

      Glenmark Pharma may rally upto Rs 400, says PN Vijay, Portfolio Manager, www.askpnvijay.com.

    • Cipla, Glenmark better bets: Rahul Mohindar

      Cipla, Glenmark better bets in pharma space, says Rahul Mohindar, Director, viratechindia.com

    • Glenmark Pharma has target of Rs 250: Sukhani

      Glenmark Pharma has target of Rs 250, says Sudarshan Sukhani, s2analytics.com.

    • Buy Glenmark Pharma above Rs 300: Kulkarni

      Buy Glenmark Pharma above Rs 300, says Shardul Kulkarni of Angel Broking.

    • Choksey's view on Reliance Industries

      Deven Choksey, MD, KR Choksey Securities share his view on Reliance Industries.

    • Glenmark Pharma may touch Rs 360: Mohindar

      Glenmark Pharma may touch Rs 360, says Rahul Mohindar, Director, viratechindia.com.

    • Pharma, FMGC safe space for investment: Mohindar

      Pharma and FMGC safe space for investment, says Rahul Mohindar, Director, viratechindia.com.

    • Bull's Eye: Buy BHEL, SBI, Delta Corp; short Tata Steel

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Glenmark Pharma best pick in pharma space: Diwan

      Glenmark Pharma is a best pick in pharma space, says Prakash Diwan, Asit C Mehta Investment.

    • Invest in Glenmark Pharma: Prakash Diwan

      Prakash Diwan of Asit C Mehta feels that one should invest in Glenmark Pharma.

    • Enter Idea Cellular around Rs 90: Manghnani

      Anil Manghnani, Modern Shares & Stock Brokers feels investors can enter in Idea Cellular around Rs 90.

    • Cipla a best stock in pharma space: Bala

      Jai Bala, Chief Market Technician, Cashthechaos.com feels the best setup in the pharmaceutical space is Cipla.

    • Invest in Wockhardt, says Salil Sharma

      Invest in Wockhardt, says Salil Sharma of Kapur Sharma & Co.

    • Invest in Glenmark Pharma: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas advises to invest in Glenmark Pharma.

    • Buy Glenmark Pharma: Ranak Merchant

      Ranak Merchan of Sushil Finance advised buying Glenmark Pharma.

    • Lupin has target of Rs 530: Pankaj Pandey

      Lupin has target of Rs 530, says Pankaj Pandey, Head of Research, ICICI Direct.

    • Glenmark, Strides Acrolab top picks among pharma pack: Jain

      Glenmark, Strides Acrolabs top picks among pharma sector, says Rajesh Jain, Independent Market Strategist.

    • Buy ITC on dips: Anil Manghnani

      Buy ITC on dips, says Anil Manghnani of Modern Shares & Stock Brokers.

    • Buy Glenmark Pharma, says Deven Choksey

      Buy Glenmark Pharma, says Deven Choksey, MD, KR Choksey Shares and Securities.

    • Buy Ranbaxy on decline: Jain

      Buy Ranbaxy on decline, says Rajesh Jain, Independent Market Strategist.

    • Buy Glenmark Pharma above Rs 320: Mohindar

      Buy Glenmark Pharma above Rs 320, says Rahul Mohindar of Viratechindia.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347